Capuramycin

Class: MraY inhibitor (nucleoside antibiotic)

Spectrum of activity:	Gram-positive
Details of activity:	Interferes with cell-wall synthesis by inhibiting transfer of the peptidoglycan precursor moiety (MurNAc-pentapeptide) to the membrane lipid carrier, undecaprenyl phosphate. Activity against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
Description:	Natural product produced by Streptomyces; total synthesis and several analogues
Year first mentioned:	1986
Development status:	Experimental

Chemical structure(s):
Canonical SMILES:	CO[C@H]1[C@H]([C@H](N2C=CC(=O)NC2=O)O[C@@H]1[C@H](C(=O)N)O[C@@H]3[C@H]([C@H](C=C(C(=O)N[C@H]4CCCCNC4=O)O3)O)O)O
Isomeric SMILES:	CO[C@H]1[C@H]([C@@H](O[C@@H]1[C@H](C(=O)N)O[C@@H]2[C@H]([C@H](C=C(O2)C(=O)N[C@H]3CCCCNC3=O)O)O)N4C=CC(=O)NC4=O)O
InChI:	InChI=1S/C23H31N5O12/c1-37-15-14(32)21(28-7-5-12(30)27-23(28)36)39-16(15)17(18(24)33)40-22-13(31)10(29)8-11(38-22)20(35)26-9-4-2-3-6-25-19(9)34/h5,7-10,13-17,21-22,29,31-32H,2-4,6H2,1H3,(H2,24,33)(H,25,34)(H,26,35)(H,27,30,36)/t9-,10-,13-,14+,15-,16-,17+,21+,22+/m0/s1
InChI Key:	BISOEENGZHMDEO-RLXIHFJVSA-N
Structure link:	https://pubchem.ncbi.nlm.nih.gov/compound/5487121

External links:
Guide to Pharmacology:	capuramycin
Main Source:	https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/ejoc.202100613
Citation:	https://academic.oup.com/jac/article/65/12/2590/755702